Literature DB >> 31904582

Hepatitis C virus-specific CD4+ T cell phenotype and function in different infection outcomes.

Diana Y Chen1, David Wolski1, Jasneet Aneja1,2, Lyndon Matsubara1, Brandon Robilotti1, Garrett Hauck1, Paulo Sergio Fonseca de Sousa3, Sonu Subudhi1, Carlos Augusto Fernandes4, Ruben C Hoogeveen1, Arthur Y Kim2, Lia Lewis-Ximenez3, Georg M Lauer1.   

Abstract

CD4+ T cell failure is a hallmark of chronic hepatitis C virus (HCV) infection. However, the mechanisms underlying the impairment and loss of virus-specific CD4+ T cells in persisting HCV infection remain unclear. Here we examined HCV-specific CD4+ T cells longitudinally during acute infection with different infection outcomes. We found that HCV-specific CD4+ T cells are characterized by expression of a narrower range of T cell inhibitory receptors compared with CD8+ T cells, with initially high expression levels of PD-1 and CTLA-4 that were associated with negative regulation of proliferation in all patients, irrespective of outcome. In addition, HCV-specific CD4+ T cells were phenotypically similar during early resolving and persistent infection and secreted similar levels of cytokines. However, upon viral control, CD4+ T cells quickly downregulated inhibitory receptors and differentiated into long-lived memory cells. In contrast, persisting viremia continued to drive T cell activation and PD-1 and CTLA-4 expression, and blocked T cell differentiation, until the cells quickly disappeared from the circulation. Our data support an important and physiological role for inhibitory receptor-mediated regulation of CD4+ T cells in early HCV infection, irrespective of outcome, with persistent HCV viremia leading to sustained upregulation of PD-1 and CTLA-4.

Entities:  

Keywords:  Adaptive immunity; Hepatitis; Immunology; Infectious disease; T cells

Mesh:

Substances:

Year:  2020        PMID: 31904582      PMCID: PMC6994113          DOI: 10.1172/JCI126277

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus.

Authors:  N H Gruener; F Lechner; M C Jung; H Diepolder; T Gerlach; G Lauer; B Walker; J Sullivan; R Phillips; G R Pape; P Klenerman
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.

Authors:  Bijan Raziorrouh; Axel Ulsenheimer; Winfried Schraut; Malte Heeg; Peter Kurktschiev; Reinhart Zachoval; Maria-Christina Jung; Robert Thimme; Christoph Neumann-Haefelin; Sophia Horster; Martin Wächtler; Michael Spannagl; Jürgen Haas; Helmut M Diepolder; Norbert H Grüner
Journal:  Gastroenterology       Date:  2011-07-18       Impact factor: 22.682

3.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

4.  High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome.

Authors:  Victoria Kasprowicz; Julian Schulze Zur Wiesch; Thomas Kuntzen; Brian E Nolan; Steven Longworth; Andrew Berical; Jenna Blum; Cory McMahon; Laura L Reyor; Nahel Elias; William W Kwok; Barbara G McGovern; Gordon Freeman; Raymond T Chung; Paul Klenerman; Lia Lewis-Ximenez; Bruce D Walker; Todd M Allen; Arthur Y Kim; Georg M Lauer
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

5.  HCV persistence and immune evasion in the absence of memory T cell help.

Authors:  Arash Grakoui; Naglaa H Shoukry; David J Woollard; Jin-Hwan Han; Holly L Hanson; John Ghrayeb; Krishna K Murthy; Charles M Rice; Christopher M Walker
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

6.  Signatures of protective memory immune responses during hepatitis C virus reinfection.

Authors:  Mohamed S Abdel-Hakeem; Nathalie Bédard; Donald Murphy; Julie Bruneau; Naglaa H Shoukry
Journal:  Gastroenterology       Date:  2014-07-16       Impact factor: 22.682

7.  Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence.

Authors:  Julian Schulze Zur Wiesch; Donatella Ciuffreda; Lia Lewis-Ximenez; Victoria Kasprowicz; Brian E Nolan; Hendrik Streeck; Jasneet Aneja; Laura L Reyor; Todd M Allen; Ansgar W Lohse; Barbara McGovern; Raymond T Chung; William W Kwok; Arthur Y Kim; Georg M Lauer
Journal:  J Exp Med       Date:  2012-01-02       Impact factor: 14.307

8.  PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.

Authors:  Constantinos Petrovas; Joseph P Casazza; Jason M Brenchley; David A Price; Emma Gostick; William C Adams; Melissa L Precopio; Timothy Schacker; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Exp Med       Date:  2006-09-05       Impact factor: 14.307

9.  SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection.

Authors:  Constantinos Petrovas; David A Price; Joseph Mattapallil; David R Ambrozak; Christof Geldmacher; Valentina Cecchinato; Monica Vaccari; Elzbieta Tryniszewska; Emma Gostick; Mario Roederer; Daniel C Douek; Sara H Morgan; Simon J Davis; Genoveffa Franchini; Richard A Koup
Journal:  Blood       Date:  2007-04-17       Impact factor: 22.113

10.  Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.

Authors:  Priya Duggal; Chloe L Thio; Genevieve L Wojcik; James J Goedert; Alessandra Mangia; Rachel Latanich; Arthur Y Kim; Georg M Lauer; Raymond T Chung; Marion G Peters; Gregory D Kirk; Shruti H Mehta; Andrea L Cox; Salim I Khakoo; Laurent Alric; Matthew E Cramp; Sharyne M Donfield; Brian R Edlin; Leslie H Tobler; Michael P Busch; Graeme Alexander; Hugo R Rosen; Xiaojiang Gao; Mohamed Abdel-Hamid; Richard Apps; Mary Carrington; David L Thomas
Journal:  Ann Intern Med       Date:  2013-02-19       Impact factor: 25.391

View more
  14 in total

1.  Deciphering the Plasmodium falciparum malaria-specific CD4+ T-cell response: ex vivo detection of high frequencies of PD-1+TIGIT+ EXP1-specific CD4+ T cells using a novel HLA-DR11-restricted MHC class II tetramer.

Authors:  Sophia Schulte; Janna Heide; Christin Ackermann; Sven Peine; Michael Ramharter; Maria Sophia Mackroth; Robin Woost; Thomas Jacobs; Julian Schulze Zur Wiesch
Journal:  Clin Exp Immunol       Date:  2022-04-04       Impact factor: 4.330

Review 2.  T cell responses during HBV and HCV infections: similar but not quite the same?

Authors:  Naglaa H Shoukry; Christopher M Walker
Journal:  Curr Opin Virol       Date:  2021-10-04       Impact factor: 7.121

3.  CD4+ T cell responses in human viral infection: lessons from hepatitis C.

Authors:  Benedikt Binder; Robert Thimme
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

Review 4.  Immune system control of hepatitis C virus infection.

Authors:  Johnasha D Stuart; Eduardo Salinas; Arash Grakoui
Journal:  Curr Opin Virol       Date:  2020-11-01       Impact factor: 7.090

5.  Adenovirus-vectored T cell vaccine for hepacivirus shows reduced effectiveness against a CD8 T cell escape variant in rats.

Authors:  Alex S Hartlage; Piyush Dravid; Christopher M Walker; Amit Kapoor
Journal:  PLoS Pathog       Date:  2021-03-18       Impact factor: 6.823

6.  Immune Activation Induces Telomeric DNA Damage and Promotes Short-Lived Effector T Cell Differentiation in Chronic HCV Infection.

Authors:  Lam Nhat Nguyen; Lam Ngoc Thao Nguyen; Juan Zhao; Madison Schank; Xindi Dang; Dechao Cao; Sushant Khanal; Bal Krishna Chand Thakuri; Jinyu Zhang; Zeyuan Lu; Xiao Y Wu; Mohamed El Gazzar; Shunbin Ning; Ling Wang; Jonathan P Moorman; Zhi Q Yao
Journal:  Hepatology       Date:  2021-08-25       Impact factor: 17.425

7.  Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Plasmodium falciparum Malaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease.

Authors:  Marissa Herrmann; Sophia Schulte; Nils H Wildner; Melanie Wittner; Thomas Theo Brehm; Michael Ramharter; Robin Woost; Ansgar W Lohse; Thomas Jacobs; Julian Schulze Zur Wiesch
Journal:  Front Immunol       Date:  2020-08-26       Impact factor: 7.561

Review 8.  Adaptive Immune Response against Hepatitis C Virus.

Authors:  Janine Kemming; Robert Thimme; Christoph Neumann-Haefelin
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

Review 9.  Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal.

Authors:  Alip Ghosh; Sara Romani; Shyam Kottilil; Bhawna Poonia
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

Review 10.  Where to Next? Research Directions after the First Hepatitis C Vaccine Efficacy Trial.

Authors:  Christopher C Phelps; Christopher M Walker; Jonathan R Honegger
Journal:  Viruses       Date:  2021-07-13       Impact factor: 5.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.